eghorani's library 148 articles Export Sort

Hide details

	Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. [My Copy] Chest, Vol. 101, No. 6. (1 June 1992), pp. 1644-1655. by R. C. Bone, R. A. Balk, F. B. Cerra, et al.R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, W. J. Sibbald posted to sepsis by eghorani on 2009-10-24 12:36:57 as along with 3 people one32 jlassiter simdoc
	B-Cell Epitope Spreading Is a Critical Step for the Switch from C-Protein-Induced Myocarditis to Dilated Cardiomyopathy [My Copy] American Journal of Pathology, Vol. 170, No. 1. (1 January 2007), pp. 43-51. by Matsumoto, Yoh, Park, Il-Kwon, Kohyama, Kuniko posted to no-tag by eghorani on 2009-05-15 18:01:30 as
	Coxsackievirus B3 Induces T Regulatory Cells, Which Inhibit Cardiomyopathy in Tumor Necrosis Factor-alpha Transgenic Mice [My Copy] Circ Res, Vol. 99, No. 10. (10 November 2006), pp. 1109-1116. by Sally A. Huber, Arthur M. Feldman, Danielle Sartini posted to no-tag by eghorani on 2009-05-15 17:36:13 as
	Significance of detection of enterovirus RNA in myocardial tissues by reverse transcription-polymerase chain reaction [My Copy] International Journal of Cardiology, Vol. 51, No. 2. (September 1995), pp. 157-164. by H. Ueno posted to no-tag by eghorani on 2009-05-15 16:20:04 as
	An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus [My Copy] Circulation, Vol. 66, No. 2. (1 August 1982), pp. 355-360. by A. Matsumori, C. Kawai posted to no-tag by eghorani on 2009-05-15 15:48:15 as
	Transformation of myocarditis and inflammatory cardiomyopathy to idiopathic dilated cardiomyopathy: facts and fiction [My Copy] Medical Microbiology and Immunology, Vol. 193, No. 2. (1 May 2004), pp. 61-64. by Hansr Figulla posted to no-tag by eghorani on 2009-05-15 12:03:54 as
	A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. [My Copy] N Engl J Med, Vol. 333, No. 5. (3 August 1995), pp. 269-275. by J. W. Mason, J. B. O'Connell, A. Herskowitz, et al.N. R. Rose, B. M. McManus, M. E. Billingham, T. E. Moon posted to no-tag by eghorani on 2009-05-15 12:02:42 as along with 1 person wilvc
	The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID) [My Copy] Herz, Vol. 25, No. 3. (1 June 2000), pp. 279-285. by Günther Hufnagel, Sabine Pankuweit, Annette Richter, Ute Schönian, Bernhard Maisch posted to no-tag by eghorani on 2009-05-15 12:02:24 as
	Myocarditis: Current Trends in Diagnosis and Treatment [My Copy] Circulation, Vol. 113, No. 6. (14 February 2006), pp. 876-890. by Jared W. Magnani, William G. Dec posted to no-tag by eghorani on 2009-05-15 12:00:00 as
	Vaccination with EGF active immunotherapy improves survival in advanced non small cell lung cancer (NSCLC) patients: Interim analysis of a randomized phase II trial [My Copy] J Clin Oncol (Meeting Abstracts), Vol. 23, No. 16_suppl. (1 June 2005), 7210. by E. Neninger, T. Crombet, M. Osorio, et al.M. Catala, A. Torre, I. Leonard, B. Garcia, P. Marinello, G. Gonzalez, A. Lage posted to no-tag by eghorani on 2009-03-23 22:31:31 as
	Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity. [My Copy] Journal of molecular recognition : JMR, Vol. 6, No. 2. (June 1993), pp. 81-94. by P. T. Kaumaya, S. Kobs-Conrad, Y. H. Seo, et al.H. Lee, A. M. VanBuskirk, N. Feng, J. F. Sheridan, V. Stevens posted to no-tag by eghorani on 2009-03-12 20:06:18 as
	Role of neutrophils in BCG immunotherapy for bladder cancer. [My Copy] Urologic oncology, Vol. 26, No. 4. (g 2008), pp. 341-345. by M. P. Simons, M. A. O'Donnell, T. S. Griffith posted to no-tag by eghorani on 2009-03-12 20:05:48 as
	The three Es of cancer immunoediting. [My Copy] Annual review of immunology, Vol. 22 (2004), pp. 329-360. by G. P. Dunn, L. J. Old, R. D. Schreiber posted to no-tag by eghorani on 2009-03-12 00:28:50 as along with 2 people Zephyrus eisei
	Cancer vaccines: between the idea and the reality [My Copy] Nat Rev Immunol, Vol. 3, No. 8. (2003), pp. 630-641. by Olivera J. Finn posted to no-tag by eghorani on 2009-03-12 00:15:31 as
	Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy [My Copy] Ann Oncol, Vol. 14, No. 3. (1 March 2003), pp. 461-466. by G. Gonzalez, T. Crombet, F. Torres, et al.M. Catala, L. Alfonso, M. Osorio, E. Neninger, B. Garcia, A. Mulet, R. Perez, R. Lage posted to no-tag by eghorani on 2009-03-11 23:35:32 as
	Final results of a multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of MAGE-A3 immunotherapeutic as adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC) [My Copy] J Clin Oncol (Meeting Abstracts), Vol. 25, No. 18_suppl. (20 June 2007), 7554. by J. Vansteenkiste, M. Zielinski, A. Linder, et al.J. Dahabre, E. Esteban, W. Malinowski, J. Jassem, B. Passlick, F. Lehmann, V. G. Brichard posted to no-tag by eghorani on 2009-03-11 23:09:12 as
	Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma. [My Copy] International journal of cancer. Journal international du cancer, Vol. 117, No. 4. (20 November 2005), pp. 596-604. by W. H. Kruit, H. H. van Ojik, V. G. Brichard, et al.B. Escudier, T. Dorval, B. Dréno, P. Patel, N. van Baren, M. F. Avril, S. Piperno, A. Khammari, M. Stas, G. Ritter, B. Lethé, D. Godelaine, F. Brasseur, Y. Zhang, P. van der Bruggen, T. Boon, A. M. Eggermont, M. Marchand posted to no-tag by eghorani on 2009-03-11 23:02:46 as
	Anti-ganglioside anti-idiotypic monoclonal antibody-based cancer vaccine induces apoptosis and antiangiogenic effect in a metastatic lung carcinoma [My Copy] Cancer Immunology, Immunotherapy by Y. Diaz, A. Gonzalez, A. Lopez, R. Perez, A. Vazquez, E. Montero posted to no-tag by eghorani on 2009-03-11 22:48:20 as
	Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: report of a phase I trial. [My Copy] Cancer biology & therapy, Vol. 6, No. 2. (February 2007), pp. 145-150. by E. Neninger, R. M. Díaz, A. de la Torre, et al.R. Rives, A. Díaz, G. Saurez, M. R. Gabri, D. F. Alonso, B. Wilkinson, A. M. Alfonso, T. Combet, R. Pérez, A. M. Vázquez posted to no-tag by eghorani on 2009-03-11 22:47:28 as
	Tumor-Associated Carbohydrate Antigens [My Copy] Annual Review of Immunology, Vol. 2, No. 1. (1984), pp. 103-126. by Sen I. Hakomori posted to no-tag by eghorani on 2009-03-11 22:07:35 as
	Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non-Small-Cell Lung Cancer [My Copy] J Clin Oncol, Vol. 23, No. 27. (20 September 2005), pp. 6674-6681. by Charles Butts, Nevin Murray, Andrew Maksymiuk, et al.Glenwood Goss, Ernie Marshall, Denis Soulieres, Yvon Cormier, Peter Ellis, Allan Price, Ravinder Sawhney, Mary Davis, Janine Mansi, Colum Smith, Dimitrios Vergidis, Paul Ellis, Mary Macneil, Martin Palmer posted to no-tag by eghorani on 2009-03-11 20:32:41 as
	Vaccination with BLP25 liposome vaccine to treat non-small cell lung and prostate cancers. [My Copy] Expert review of vaccines, Vol. 4, No. 3. (June 2005), pp. 249-257. by S. North, C. Butts posted to no-tag by eghorani on 2009-03-11 20:12:41 as
	L-BLP25: A Peptide Vaccine Strategy in Non Small Cell Lung Cancer [My Copy] Clin Cancer Res, Vol. 13, No. 15. (1 August 2007), pp. 4652s-4654. by Randeep Sangha, Charles Butts posted to no-tag by eghorani on 2009-03-11 20:05:34 as
	What makes MUC1 a tumor antigen? [My Copy] Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, Vol. 26, No. 4. (g 2005), pp. 217-220. by U. Karsten, S. von Mensdorff-Pouilly, S. Goletz posted to no-tag by eghorani on 2009-03-11 19:57:06 as
	Lung cancer immunotherapy. [My Copy] Clinical medicine & research, Vol. 3, No. 4. (November 2005), pp. 221-228. by L. E. Raez, S. Fein, E. R. Podack posted to no-tag by eghorani on 2009-03-11 18:49:50 as
	Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine® [My Copy] Seminars in Cancer Biology, Vol. 13, No. 6. (December 2003), pp. 409-415. by V. Sondak posted to no-tag by eghorani on 2009-03-11 16:18:43 as
	Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going? [My Copy] J. Natl. Cancer Inst., Vol. 94, No. 11. (5 June 2002), pp. 805-818. by Giorgio Parmiani, Chiara Castelli, Piero Dalerba, et al.Roberta Mortarini, Licia Rivoltini, Francesco M. Marincola, Andrea Anichini posted to no-tag by eghorani on 2009-03-11 15:30:16 as
	Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 5, No. 6. (June 1999), pp. 1319-1323. by S. C. Grant, M. G. Kris, A. N. Houghton, P. B. Chapman posted to no-tag by eghorani on 2009-03-11 14:56:38 as
	Phase III Study of Adjuvant Vaccination With Bec2/Bacille Calmette-Guerin in Responding Patients With Limited-Disease Small-Cell Lung Cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study) [My Copy] J Clin Oncol, Vol. 23, No. 28. (1 October 2005), pp. 6854-6864. by Giuseppe Giaccone, Channa Debruyne, Enriqueta Felip, et al.Paul B. Chapman, Stefan C. Grant, Michael Millward, Luc Thiberville, Giannicola D'Addario, Corneel Coens, Lisa S. Rome, Petr Zatloukal, Oriol Masso, Catherine Legrand posted to no-tag by eghorani on 2009-03-11 14:55:56 as
	Immunotherapy for lung cancer. [My Copy] Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Vol. 3, No. 6 Suppl 2. (June 2008) by P. A. Bradbury, F. A. Shepherd posted to no-tag by eghorani on 2009-03-03 10:20:44 as
	Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients. [My Copy] Cancer investigation, Vol. 26, No. 5. (June 2008), pp. 448-455. by T. Ren, Z. K. Wen, Z. M. Liu, et al.C. Qian, Y. J. Liang, M. L. Jin, Y. Y. Cai, L. Xu posted to no-tag by eghorani on 2009-03-03 10:19:07 as
	The Cell Biology of Macrophage Activation [My Copy] Annual Review of Immunology, Vol. 2, No. 1. (1984), pp. 283-318. by Dolph O. Adams, Thomas A. Hamilton posted to no-tag by eghorani on 2009-02-28 16:20:31 as
	Treatment of human cancer with mumps virus [My Copy] Cancer, Vol. 34, No. 6. (1974), pp. 1907-1928. by Teruo Asada posted to no-tag by eghorani on 2009-02-28 16:19:54 as
	Infantile Hodgkin's disease: remission after measles. [My Copy] British medical journal, Vol. 2, No. 5863. (19 May 1973) by H. C. Mota posted to no-tag by eghorani on 2009-02-28 16:19:19 as
	Influenza-induced expression of functional tumor necrosis factor-related apoptosis-inducing ligand on human peripheral blood mononuclear cells. [My Copy] Human immunology, Vol. 69, No. 10. (October 2008), pp. 634-646. by E. L. Brincks, T. A. Kucaba, K. L. Legge, T. S. Griffith posted to no-tag by eghorani on 2009-02-28 15:53:11 as
	A potential role of macrophage activation in the treatment of cancer. [My Copy] Critical reviews in oncology/hematology, Vol. 44, No. 2. (November 2002), pp. 143-161. by A. H. Klimp, E. G. de Vries, G. L. Scherphof, T. Daemen posted to no-tag by eghorani on 2009-02-28 15:49:07 as
	Neutrophils Contribute to the Measles Virus-induced Antitumor Effect: Enhancement by Granulocyte Macrophage Colony-stimulating Factor Expression [My Copy] Cancer Res, Vol. 63, No. 19. (1 October 2003), pp. 6463-6468. by Deanna Grote, Roberto Cattaneo, Adele K. Fielding posted to no-tag by eghorani on 2009-02-28 15:48:21 as
	Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. [My Copy] Blood, Vol. 97, No. 12. (15 June 2001), pp. 3746-3754. by D. Grote, S. J. Russell, T. I. Cornu, et al.R. Cattaneo, R. Vile, G. A. Poland, A. K. Fielding posted to no-tag by eghorani on 2009-02-28 15:48:06 as
	A potential role of macrophage activation in the treatment of cancer [My Copy] Critical Reviews in Oncology/Hematology, Vol. 44, No. 2. (November 2002), pp. 143-161. by E. Devries, G. Scherphof, T. Daemen posted to no-tag by eghorani on 2009-02-28 15:46:56 as
	Neutrophil-Derived TNF-Related Apoptosis-Inducing Ligand (TRAIL): A Novel Mechanism of Antitumor Effect by Neutrophils [My Copy] Cancer Res, Vol. 64, No. 3. (1 February 2004), pp. 1037-1043. by Yuhki Koga, Akinobu Matsuzaki, Aiko Suminoe, Hiroyoshi Hattori, Toshiro Hara posted to no-tag by eghorani on 2009-02-28 14:43:59 as
	Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. [My Copy] FEBS letters, Vol. 545, No. 2-3. (19 June 2003), pp. 177-182. by K. Takeuchi, S. I. Kadota, M. Takeda, N. Miyajima, K. Nagata posted to no-tag by eghorani on 2009-02-28 14:35:31 as
	Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549. [My Copy] Virology, Vol. 290, No. 1. (10 November 2001), pp. 1-10. by E. Helin, R. Vainionpää, T. Hyypiä, I. Julkunen, S. Matikainen posted to no-tag by eghorani on 2009-02-28 14:35:01 as
	Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells [My Copy] J Leukoc Biol, Vol. 80, No. 6. (1 December 2006), pp. 1529-1541. by Katy Wendt, Esther Wilk, Sabine Buyny, Jan Buer, Reinhold E. Schmidt, Roland Jacobs posted to no-tag by eghorani on 2009-02-28 14:27:38 as
	The IL-12 Signature: NK Cell Terminal CD56+high Stage and Effector Functions [My Copy] J Immunol, Vol. 172, No. 1. (1 January 2004), pp. 88-96. by Matthew J. Loza, Bice Perussia posted to no-tag by eghorani on 2009-02-28 02:38:12 as
	Natural killer cells in viral infection: more than just killers [My Copy] Immunological Reviews, Vol. 214, No. 1. (December 2006), pp. 239-250. by Andoniou, E. Christopher, Andrews, M. Daniel, Degli-Esposti, A. Mariapia posted to no-tag by eghorani on 2009-02-27 20:18:08 as
	NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines [My Copy] Annual Review of Immunology, Vol. 17, No. 1. (1999), pp. 189-220. by Christine A. Biron, Khuong B. Nguyen, Gary C. Pien, Leslie P. Cousens, Thais posted to no-tag by eghorani on 2009-02-27 20:17:33 as
	Wiley InterScience :: Article :: HTML Full Text [My Copy] posted to no-tag by eghorani on 2009-02-27 20:03:28 as
	Keeping NK cells in highly regulated antiviral warfare [My Copy] Trends in Immunology, Vol. 28, No. 6. (June 2007), pp. 252-259. by S. Lee, T. Miyagi, C. Biron posted to no-tag by eghorani on 2009-02-27 19:45:49 as
	Immunobiology [My Copy] (18 June 2004) by C. Janeway posted to no-tag by eghorani on 2009-02-27 18:05:28 as along with 2 people jjray endo_anaphy2
	Antitumor response of CD14+/CD16+ monocyte subpopulation. [My Copy] Experimental hematology, Vol. 32, No. 8. (August 2004), pp. 748-755. by A. Szaflarska, M. Baj-Krzyworzeka, M. Siedlar, et al.K. Weglarczyk, I. Ruggiero, B. Hajto, M. Zembala posted to no-tag by eghorani on 2009-02-27 17:22:10 as